The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex complicated chemical process. Preliminary routes focused on protein portion coupling, utilizing solid-phase https://jadaplhn960961.ssnblog.com/39406393/synthesis-and-investigation-implementations-of-retatrutide